# Mettler Toledo International Inc/: Form 10-Q for the period ended Mar 31, 2014

- Company: [Mettler Toledo International Inc/](/companies/mtd.md) (CIK 1037646)
- Form: 10-Q
- Filed: 2014-05-09
- Accepted by EDGAR: May 9, 2014, 09:51 ET
- Period: 2014-03-31
- Accession: 0001037646-14-000011
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1037646/000103764614000011/mtd_10qx3312014.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1037646/000103764614000011/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-01-01 to 2014-03-31 | $550.6m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2014-01-01 to 2014-03-31 | $181.2m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2014-01-01 to 2014-03-31 | $292.6m | us-gaap:GrossProfit |
| Research and development | 3 months, 2014-01-01 to 2014-03-31 | $29.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2014-01-01 to 2014-03-31 | $172.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2014-01-01 to 2014-03-31 | $5.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-01-01 to 2014-03-31 | $18.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-01-01 to 2014-03-31 | $58.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-01-01 to 2014-03-31 | $1.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-01-01 to 2014-03-31 | $1.98 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-01-01 to 2014-03-31 | 30,088,245 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2014-01-01 to 2014-03-31 | $42.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2014-01-01 to 2014-03-31 | $16.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2014-01-01 to 2014-03-31 | $82.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-03-31 | $115.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-03-31 | $890.1m | us-gaap:AssetsCurrent |
| Total assets | at 2014-03-31 | $2.14bn | us-gaap:Assets |
| Current liabilities | at 2014-03-31 | $509.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-03-31 | $1.21bn | us-gaap:Liabilities |
| Long-term debt | at 2014-03-31 | $449.6m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2014-03-31 | $923.6m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2014-03-31 | 29,220,329 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 23,855 characters.

*The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Unaudited Interim Consolidated Financial Statements included herein.*

### General

Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results to be expected for the full year ending December 31, 2014.

Local currency changes exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results.

### Results of Operations – Consolidated

The following tables set forth certain items from our interim consolidated statements of operations and comprehensive income for the three month periods ended March 31, 2014 and 2013 (amounts in thousands).

|  | Three months ended March 31, 2014 (unaudited)% |  | 2013 (unaudited)% |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $550,621 | 100.0 | $524,355 | 100.0 |
| Cost of sales | 257,980 | 46.9 | 245,197 | 46.8 |
| Gross profit | 292,641 | 53.1 | 279,158 | 53.2 |
| Research and development | 29,497 | 5.4 | 27,700 | 5.3 |
| Selling, general and administrative | 172,191 | 31.3 | 166,025 | 31.7 |
| Amortization | 7,094 | 1.3 | 5,122 | 1.0 |
| Interest expense | 5,666 | 1.0 | 5,400 | 1.0 |
| Restructuring charges | 1,492 | 0.3 | 5,002 | 1.0 |
| Other charges (income), net | 317 | — | 773 | — |
| Earnings before taxes | 76,384 | 13.8 | 69,136 | 13.2 |
| Provision for taxes | 18,333 | 3.3 | 16,592 | 3.2 |
| Net earnings | $58,051 | 10.5 | $52,544 | 10.0 |

#### Net sales

Net sales were $550.6 million for the three months ended March 31, 2014, compared to $524.4 million for the corresponding period in 2013. This represents an increase in U.S. dollars of 5%. Excluding the effect of currency exchange rate fluctuations, or in local currencies, net sales increased 4% for the three months ended March 31, 2014. Market conditions improved during the three months ended March 31, 2014, particularly in Europe. However global market conditions remain uncertain, especially in emerging markets, and we continue to be cautious regarding our sales growth outlook.

Net sales by geographic destination for the three months ended March 31, 2014, in U.S. dollars increased 2% in the Americas, 12% in Europe and were flat in Asia/Rest of World. In local currencies, our net sales by geographic destination increased 3% in the Americas, 9% in Europe and 1% in Asia/Rest of World. Net sales in local currencies for Asia/Rest of World for the three months ended 2014 were reduced by approximately 1% due to the exit of certain industrial-related businesses in China. A discussion of sales by operating segment is included below.

As described in Note 18 to our consolidated financial statements for the year ended December 31, 2013, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance and spare parts.

Net sales of products increased 5% in U.S. dollars and 4% in local currency for the three months ended March 31, 2014 compared to the prior period. Service revenue (including spare parts) increased 5% in both U.S. dollars and local currency during the three months ended March 31, 2014 compared to the corresponding period in 2013.

Net sales of our laboratory-related products, which represented approximately 47% of our total net sales for the three months ended March 31, 2014, increased 7% in both U.S. dollars and local currencies during the three months ended March 31, 2014 principally driven by strong volume and favorable price realization in most categories, especially analytical instruments and laboratory balances.

Net sales of our industrial-related products, which represented approximately 44% of our total net sales for the three months ended March 31, 2014, increased 2% in U.S. dollars and 1% in local currencies during the three months ended March 31, 2014. We experienced solid sales growth in our core-industrial products in the Americas and Europe related to higher sales volumes and favorable price realization during the three months ended March 31, 2014. These results were offset by a sales volume decline in core-industrial products in Asia/Rest of World, particularly China. Overall Chinese market conditions for our industrial products remain weak. Growth in China can be expected to be volatile and the timing of a recovery can be uncertain.

Net sales in our food retailing markets, which represented approximately 9% of our total net sales for the three months ended March 31, 2014, increased 10% in U.S. dollars and 8% in local currencies during the three months ended March 31, 2014, with particularly strong project activity in Europe.

#### Gross profit

Gross profit as a percentage of net sales was 53.1% for the three months ended March 31, 2014 compared to 53.2% for the corresponding period in 2013.

Gross profit as a percentage of net sales for products was 57.1% for both the three month periods ended March 31, 2014 and 2013.

Gross profit as a percentage of net sales for services (including spare parts) was 40.2% for the three months ended March 31, 2014 compared to 40.5% for the corresponding period in 2013.

The decrease in gross profit as a percentage of net sales for the three months ended March 31, 2014 includes unfavorable currency, business mix and other charges, offset in part by increased price realization and reduced material costs.

#### Research and development and selling, general and administrative expenses

Research and development expenses as a percentage of net sales were 5.4% for the three months ended March 31, 2014 compared to 5.3% for the corresponding period during 2013. Research and development expenses increased 6% in U.S. dollars and 4% in local currencies, during the three months ended March 31, 2014 compared to the corresponding period in 2013 relating to the timing of research and development project activity.

Selling, general and administrative expenses as a percentage of net sales were 31.3% for the three months ended March 31, 2014 compared to 31.7% in the corresponding period during 2013. Selling, general and administrative expenses increased 4% in U.S. dollars and 3% in local currencies, during the three months ended March 31, 2014 compared to the corresponding period in 2013. The increase includes higher cash incentive compensation as compared to prior year, partially offset by lower employee benefit costs.

#### Amortization, interest expense, other charges (income), net and taxes

Amortization expense was $7.1 million for the three months ended March 31, 2014 and $5.1 million for the corresponding period in 2013. The increase in amortization expense is primarily related to recent investment in information technology, including the Company's Blue Ocean program.

Interest expense was $5.7 million for the three months ended March 31, 2014 and $5.4 million for the corresponding period in 2013. The increase in interest expense for the three month period ended March 31, 2014 is primarily a result of an increase in average borrowings.

Other charges (income), net consists primarily of (gains) losses from foreign currency transactions, interest income and other items.

The provision for taxes is based upon using our projected annual effective tax rate of 24% for the three month periods ended March 31, 2014 and 2013. Our consolidated income tax rate is lower than the U.S. statutory rate primarily because of benefits from lower-taxed non-U.S. operations. The most significant of these lower-taxed operations are in Switzerland and China.

### Results of Operations – by Operating Segment

The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. A more detailed description of these segments is outlined in Note 18 to our consolidated financial statements for the year ended December 31, 2013.

#### U.S. Operations (amounts in thousands)

|  | Three months ended March 31, |  |
| --- | ---: | ---: |
|  | 2014 | 2013% |
| Total net sales | $184,769 | $176,766 5% |
| Net sales to external customers | $163,994 | $158,389 4% |
| Segment profit | $23,695 | $24,657 (4)% |

Total net sales and net sales to external customers increased 5% and 4%, respectively for the three months ended March 31, 2014 compared with the corresponding period in 2013. The increase in total net sales and net sales to external customers for the three months ended March 31, 2014 primarily reflects strong growth in laboratory balances and core-industrial products due to increased sales volume and favorable price realization.

Segment profit decreased $1.0 million for the three months ended March 31, 2014 compared to the corresponding period in 2013 primarily related to investments in our product inspection businesses.

#### Swiss Operations (amounts in thousands)

|  | Three months ended March 31, 2014 | 2013 | %1) |
| --- | ---: | ---: | ---: |
| Total net sales | $140,281 | $127,820 | 10% |
| Net sales to external customers | $32,056 | $30,697 | 4% |
| Segment profit | $36,166 | $34,201 | 6% |

1\) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales increased 10% in U.S. dollars and 5% in local currency for the three months ended March 31, 2014 compared to the corresponding period in 2013. Net sales to external customers increased 4% in U.S. dollars and 1% in local currency during the three months ended March 31, 2014 compared to the corresponding period in 2013. The increase in local currency net sales to external customers for the three month period ended March 31, 2014 primarily related to sales volume increases in our laboratory-related products, particularly in analytical instruments offset in part by a decline in core-industrial products.

Segment profit increased $2.0 million for the three month period ended March 31, 2014 compared to the corresponding period in 2013. Segment profit includes the impact of increased sales, partially offset by unfavorable currency.

#### Western European Operations (amounts in thousands)

|  | Three months ended March 31, 2014 | 2013 | %1) |
| --- | ---: | ---: | ---: |
| Total net sales | $190,955 | $174,280 | 10% |
| Net sales to external customers | $161,517 | $146,168 | 11% |
| Segment profit | $20,876 | $18,298 | 14% |

1\) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales increased 10% in U.S. dollars and 5% in local currency during the three month period ended March 31, 2014 compared to the corresponding period in 2013. Net sales to external customers increased 11% in U.S. dollars and 7% in local currency for the same period versus the prior year comparable period. Total net sales and net sales to external customers for the three months ended March 31, 2014 includes volume increases and favorable price realization across most product categories, particularly in laboratory balances and core-industrial products, as well as strong project activity in food retailing.

Segment profit increased $2.6 million for the three month period ended March 31, 2014 compared to the corresponding period in 2013 primarily due to increased sales and benefits from our cost reduction activities.

#### Chinese Operations (amounts in thousands)

|  | Three months ended March 31, 2014 | 2013 | %1) |
| --- | ---: | ---: | ---: |
| Total net sales | $127,165 | $121,129 | 5% |
| Net sales to external customers | $91,621 | $90,727 | 1% |
| Segment profit | $25,799 | $24,648 | 5% |

1\) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales increased 5% in U.S. dollars and 2% in local currency during the three months ended March 31, 2014 compared to the corresponding period in 2013. Net sales to external customers increased 1% in U.S. dollars and decreased 1% in local currency during the three months ended March 31, 2014 as compared to the corresponding period in 2013. The decrease in net sales to external customers during the three months ended March 31, 2014 reflects a decline in sales volume of our core-industrial products offset in part by strong growth in analytical instruments and laboratory balances. Approximately 1% of the local currency sales decline in 2014 also relates to the exit of certain industrial-related businesses. Overall Chinese market conditions for our industrial products remain weak. Growth in China can be expected to be volatile and the timing of a recovery can be uncertain.

Segment profit increased $1.2 million for the three month period ended March 31, 2014 compared to the corresponding period in 2013. The increase in segment profit for the three month period ended March 31, 2014 includes increased inter-segment sales and favorable business mix.

#### Other (amounts in thousands)

|  | Three months ended March 31, 2014 | 2013 | %1) |
| --- | ---: | ---: | ---: |
| Total net sales | $102,568 | $99,794 | 3% |
| Net sales to external customers | $101,433 | $98,374 | 3% |
| Segment profit | $9,159 | $9,487 | (3)% |

1\) Represents U.S. dollar (decline) growth for net sales and segment profit.

Total net sales and net sales to external customers increased 3% in US dollars and 9% in local currency during the three month period ended March 31, 2014 compared to the corresponding period in 2013. The increase in total net sales and net sales to external customers primarily reflects increased sales volume across most product categories, particularly in Japan, Australia and Eastern Europe.

Segment profit decreased $0.3 million for the three months ended March 31, 2014 compared to the corresponding period in 2013. The decrease in segment profit is primarily due to unfavorable currency and higher inter-segment product costs, offset in part by the impacted of increased net sales.

### Liquidity and Capital Resources

Liquidity is our ability to generate sufficient cash flows from operating activities to meet our obligations and commitments. In addition, liquidity includes the ability to obtain appropriate financing. Currently, our financing requirements are primarily driven by working capital requirements, capital expenditures, share repurchases and acquisitions.

Cash provided by operating activities totaled $42.8 million during the three months ended March 31, 2014, compared to $23.7 million in the corresponding period in 2013. The increase in 2014 is primarily due to the timing of accounts receivable and tax payments compared to the three months ended March 31, 2013, offset in part by increased inventory levels and cash incentive payments.

Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment and the purchase and expansion of facilities. Our capital expenditures totaled $16.7 million for the three months ended March 31, 2014 compared to $19.0 million in the corresponding period in 2013.

We plan to repatriate earnings from China, Switzerland, Germany, the United Kingdom and certain other countries in future years and expect the only additional cost associated with the repatriation of such earnings outside the United States will be withholding taxes. All other undistributed earnings are considered to be permanently reinvested. As of March 31, 2014, we have an immaterial amount of cash and cash equivalents outside the United States where undistributed earnings are considered permanently reinvested. Accordingly, we believe the tax impact associated with repatriating our undistributed foreign earnings will not have a material effect on our liquidity.

#### Senior Notes and Credit Facility Agreement

Our debt consisted of the following at March 31, 2014:

|  | March 31, 2014 U.S. Dollar | Other Principal Trading Currencies | Total |
| --- | ---: | ---: | ---: |
| 6.30% $100 million Senior Notes due June 25, 2015 | $100,000 | $— | $100,000 |
| 3.67% $50 million Senior Notes due December 17, 2022 | 50,000 | — | 50,000 |
| 4.10% $50 million Senior Notes due September 19, 2023 | 50,000 | — | 50,000 |
| Credit agreement | 231,584 | 17,998 | 249,582 |
| Other local arrangements | — | 16,255 | 16,255 |
| Total debt | 431,584 | 34,253 | 465,837 |
| Less: current portion | — | (16,255) | (16,255) |
| Total long-term debt | $431,584 | $17,998 | $449,582 |

As of March 31, 2014, approximately $546.4 million was available under our credit agreement. Changes in exchange rates between the currencies in which we generate cash flows and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates.

We currently believe that cash flow from operating activities, together with liquidity available under our credit facility and local working capital facilities, will be sufficient to fund currently anticipated working capital needs and capital spending requirements for at least the foreseeable future.

We continue to explore potential acquisitions. In connection with any acquisition, we may incur additional indebtedness.

#### Share Repurchase Program

We have a $3 billion share repurchase program, of which there were $809.9 million of remaining common shares authorized to be repurchased under the program. We expect that the authorization will be utilized over the next few years. The share repurchases are expected to be funded from cash balances, borrowings and cash generated from operating activities. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, the stock price, trading restrictions, the level of acquisition activity and other factors.

We have purchased 21.8 million shares since the inception of the program through March 31, 2014. During the three months ended March 31, 2014 and 2013, we spent $82.5 million and $72.3 million on the repurchase of 336,188 shares and 341,109 shares at an average price per share of $245.37 and $211.94, respectively. We reissued 69,442 shares and 117,014 shares held in treasury for the exercise of stock options and restricted stock units during the three months ended March 31, 2014 and 2013, respectively.

### Effect of Currency on Results of Operations

Our earnings are affected by changing exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings go down. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also go down.

A few factors help us manage these exchange rate risks. In September 2011, the Swiss National Bank established an exchange rate floor of 1.20 Swiss francs per euro. The floor has effectively stopped the strengthening of the Swiss franc beyond the 1.20 level. We do not know how long the Swiss National Bank will maintain this exchange rate floor. Additionally, in the third quarter of 2012, we entered into foreign currency forward contracts that reduce approximately 75% of our exposure from the Swiss franc strengthening against the euro. The forward contracts expire in April 2015. Absent these forward exchange contracts, we estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.2 million annually. The impact on our earnings before tax of the Swiss franc strengthening 1% against the U.S. dollar is approximately $0.4 million annually.

We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese Renminbi. The impact on our earnings before tax of the Chinese Renminbi weakening 1% against the U.S. dollar is a loss of approximately $0.7 million annually. In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar and the Swiss franc. Based on our outstanding debt at December 31, 2013, we estimate that a 10% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $3.8 million in the reported U.S. dollar value of the debt.

### Recent Accounting Pronouncements

In January 2014, the Company adopted ASU 2013-11 "Income Taxes." The amendment provided further guidance to the balance sheet presentation of unrecognized tax benefits when a net operating loss or similar tax loss carryforwards, or a tax credit carryforward exists. The adoption of this guidance did not have a material impact to the Company's consolidated results of operations or financial position.

### Forward-Looking Statements Disclaimer

*You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. You can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue”.*

*We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position , capital expenditures, cash flow, tax-related matters, compliance with laws, and effects of acquisitions.*

*Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2013 Annual Report on Form 10-K.*

## Market risk

As filed, 174 characters.

As of March 31, 2014, there was no material change in the information provided under Item 7A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

## Controls and procedures

As filed, 772 characters.

Under the supervision and with the participation of our management, including the Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer, have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended March 31, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 201 characters.

For the three months ended March 31, 2014 there were no material changes from risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

Filed May 9, 2014.
Source: SEC EDGAR, the filing index for accession 0001037646-14-000011. Last ingested by Listed: Nov 13, 2026, 02:43 ET. No prices; not investment advice.
